Af­ter warn­ing let­ters and fa­tal poi­son­ings, FDA is­sues guid­ance for strin­gent test­ing of con­t­a­m­i­nants

Af­ter send­ing warn­ing let­ters to sev­er­al for­eign drug­mak­ers over con­t­a­m­i­nant con­cerns, the FDA to­day re­leased new guid­ance for im­me­di­ate im­ple­men­ta­tion on the test­ing of glyc­erin …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA